Jacopo Canonichesi
Perugia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Transcranial magnetic stimulation recalibrates levodopa response by attenuating neuroinflammation and glial reactivity in experimental parkinsonism.
Journal: Experimental neurology
Published: January 19, 2026
Advances in gene therapy for Lafora disease: Intravenous recombinant adeno-associated virus-mediated delivery of EPM2A and EPM2B genes.
Journal: Clinical and translational medicine
Published: July 01, 2025
Neuronal hyperexcitability: A key to unraveling hippocampal synaptic dysfunction in Lafora disease.
Journal: Epilepsia
Published: June 23, 2025
Immune control of the basal ganglia network: Interleukin-17 as a key modulator of striatal synaptic plasticity.
Journal: Neurobiology of disease
Published: February 02, 2025
Oligomeric alpha-synuclein causes early synaptic dysfunction of the corticostriatal pathway associated with non-motor symptoms.
Journal: NPJ Parkinson's disease
Published: January 14, 2025
Enhancing sleep quality in synucleinopathies through physical exercise.
Journal: Frontiers in cellular neuroscience
Published: October 23, 2024
Cerebrospinal fluid interferon-γ and development of depression in multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: August 04, 2024
Locally Synthetized 17-β-Estradiol Reverses Amyloid-β-42-Induced Hippocampal Long-Term Potentiation Deficits.
Journal: International journal of molecular sciences
Published: January 01, 2024
Gene therapy for Lafora disease in the Epm2a-/- mouse model.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 22, 2023
Cytokines, synaptic plasticity and network dynamics: a matter of balance.
Journal: Neural regeneration research
Published: July 14, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026